Cytology-based cervical screening had unequivocal success in reducing the incidence and
mortality of cervical cancer in the last century. The recognition of the role of human …

Abstract The World Health Organization (WHO) advocates population-based screening
programs to reduce the global incidence of cervical cancer. However, screening guidelines …

Background Current cancer mortality figures are important for disease management and
resource allocation. We estimated mortality counts and rates for 2020 in the European Union …

Background Cervical cancer screening has been effective in reducing incidence and
mortality of cervical cancer, leading European countries to implement screening programs …

Cervical cancer (CC) is a major gynecological problem in developing and underdeveloped
countries. Despite the significant advancement in early detection and treatment modalities …

Cervical cancer is the one of the most common cancers in women worldwide, affecting
around 570,000 new patients each year. Although there have been great improvements …

Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three
most common sexually transmitted infections (STIs) in both males and females, and the most …

Cervical cancer is relatively rare in high‐income countries, where organized screening
programs are in place, as well as opportunistic ones. As the human papillomavirus (HPV) …

Introduction Cervical cancer is one of the most common causes of morbidity and mortality
among women in developing countries including Ethiopia. Unlike other types of cancers, the …

Purpose 6-Shogaol, an active phenolic compound from ginger (Zingiber officinale), can
inhibit the growth of a variety of human cancer cells. Nevertheless, its underlying molecular …